Allergy Therapeutics PLC Stock
Price
Target price
?
?
0.000%
-
0.000%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Allergy Therapeutics PLC Stock
The Allergy Therapeutics PLC price is unchanged compared to yesterday.
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
C******** o* t** e**********
?
M***** P*******
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | 0.000% | -12.727% | -24.607% | 0.000% | -38.462% | 300.000% | -73.134% |
| Eledon Pharmaceuticals Inc. | -3.010% | 9.934% | 1.840% | 40.678% | 159.375% | 149.624% | -48.527% |
| Beximco Pharmaceuticals Ltd. GDR | 0.000% | -7.317% | -8.213% | -11.628% | -15.179% | -3.061% | -60.209% |
| SELLAS Life Sciences Group Inc | 8.310% | 11.677% | 11.343% | 455.887% | 163.139% | 408.174% | -24.798% |
News
3 Dividend Stocks Under $30 to Anchor Your Portfolio
Key Points
- Interested in AT&T Inc.? Here are five stocks we like better.
- AT&T offers a dividend yield near 5% while investing in AI-ready network infrastructure to support future growth.
- Vale
SpaceX Was Just the Beginning—2 More Massive IPOs Are on Deck
Key Points
- Interested in SpaceX? Here are five stocks we like better.
- Anthropic and OpenAI have both confidentially filed S-1s with the SEC, with analyst Luke Lango expecting two historic IPOs
Stock Market Today, June 18: Comcast Falls as Cable Pressure Builds Before July Earnings
Comcast (NASDAQ:CMCSA), a broadband, cable, streaming, studios, and theme parks provider, closed at $22.43, down 1.15%. Investors are weighing an energy-efficiency win and stake trim, while watching
